$ELTP News

Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets

Elite Pharmaceuticals Inc (ELTP) Q3 2026 Earnings Call Highlights: Record Revenue Surge and ...

Elite Pharmaceuticals Stock Dips Post Q3 Earnings Despite Revenue Jump

Elite Pharmaceuticals Q3 Earnings Call Highlights

Elite Pharmaceuticals, Inc. (ELTP) Q3 2026 Earnings Call Prepared Remarks Transcript

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information

Elite Pharmaceuticals Q3 EPS $0.01 Up From $(0.01) YoY, Sales $31.589M Up From $14.364M YoY

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026

ELTP Stock Declines Despite Solid Q2 Earnings and Revenue Performance

Elite Pharmaceuticals, Inc. (ELTP) Q2 2026 Earnings Call Transcript

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information

Elite Pharmaceuticals Receives FDA Approval for Generic Requip XL(R)

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025

ELTP Stock Gains Following Q1 Earnings Showing Strong Revenue Growth

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2026 ended June 30, 2025 and Provides Conference Call Information

Elite Pharmaceuticals Q1 EPS $(0.01), Sales $40.211M Up From $18.803M YoY

2 Outperform Rated Small Caps with Recent Pull-backs

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2026 Financial Results on August 15, 2025

Top Analyst Reports for Cisco, Caterpillar & Charles Schwab

Elite Pharmaceuticals Stock Dips Despite Record FY25 Revenue Jump